Urine Afamin and Afamin–Creatinine Ratio as Biomarkers for Kidney Injury

References

• Lichenstein HS , LyonsDE, WurfelMMet al. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J. Biol. Chem.269 ( 27 ), 18149 – 18154 (1994).
   PubMed Web of Science ®Google Scholar
• Araki T , HauptH, HermentinPet al. Preparation and partial structural characterization of alpha1T-glycoprotein from normal human plasma. Arch. Biochem. Biophys.351 ( 2 ), 250 – 256 (1998).
   PubMed Web of Science ®Google Scholar
• Voegele AF , JerkovicL, WellenzohnBet al. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry41 ( 49 ), 14532 – 14538 (2002).
   PubMed Web of Science ®Google Scholar
• Jerkovic L , VoegeleAF, ChwatalSet al. Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J. Proteome Res.4 ( 3 ), 889 – 899 (2005).
   PubMed Web of Science ®Google Scholar
• Kratzer I , BernhartE, WinterspergerAet al. Afamin is synthesized by cerebrovascular endothelial cells and mediates alpha-tocopherol transport across an in vitro model of the blood–brain barrier. J. Neurochem.108 ( 3 ), 707 – 718 (2009).
   PubMed Web of Science ®Google Scholar
• Dieplinger B , EggerM, GabrielCet al. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin. Chim. Acta425, 236 – 241 (2013).
   PubMed Web of Science ®Google Scholar
• Kronenberg F , KolleritsB, KiechlSet al. Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ. Cardiovasc. Genet.7 ( 6 ), 822 – 829 (2014).
   PubMedGoogle Scholar
• Chen YT , ChenHW, DomanskiDet al. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers. J. Proteomics75 ( 12 ), 3529 – 3545 (2012).
   PubMed Web of Science ®Google Scholar
• Zhao M , LiM, LiX, ShaoC, YinJ, GaoY. Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model. Proteome Sci.12, 42 (2014).
   PubMed Web of Science ®Google Scholar
• Kalantari S , RutishauserD, SamavatSet al. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography. PLoS ONE8 ( 12 ), e80830 (2013).
   PubMed Web of Science ®Google Scholar
• Sedic M , GethingsLA, VissersJPet al. Label-free mass spectrometric profiling of urinary proteins and metabolites from paediatric idiopathic nephrotic syndrome. Biochem. Biophys. Res. Commun.452 ( 1 ), 21 – 26 (2014).
   PubMed Web of Science ®Google Scholar
• Seeber BE , CzechT, BuchnerHet al. The vitamin E-binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis. Fertil. Steril.94 ( 7 ), 2923 – 2926 (2010).
   PubMed Web of Science ®Google Scholar
• Jackson D , CravenRA, HutsonRCet al. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer. Clin. Cancer Res.13 ( 24 ), 7370 – 7379 (2007).
   PubMed Web of Science ®Google Scholar
• Dieplinger H , AnkerstDP, BurgesAet al. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Cancer Epidemiol. Biomarkers Prev.18 ( 4 ), 1127 – 1133 (2009).
   PubMed Web of Science ®Google Scholar
• Aktas B , Kasimir-BauerS, WimbergerP, KimmigR, HeubnerM. Utility of mesothelin, L1CAM and Afamin as biomarkers in primary ovarian cancer. Anticancer Res.33 ( 1 ), 329 – 336 (2013).
   PubMed Web of Science ®Google Scholar
• Melmer A , FinederL, LaminaCet al. Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer-a study by the OVCAD consortium. Gynecol. Oncol.128 ( 1 ), 38 – 43 (2013).
   PubMed Web of Science ®Google Scholar
• Penno MA , Klingler-HoffmannM, BrazzattiJAet al. 2D-DIGE analysis of sera from transgenic mouse models reveals novel candidate protein biomarkers for human gastric cancer. J. Proteomics77, 40 – 58 (2012).
   PubMed Web of Science ®Google Scholar
• Humphries JM , PennoMA, WeilandFet al. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer. Biochim. Biophys. Acta1844 ( 5 ), 1051 – 1058 (2014).
   PubMed Web of Science ®Google Scholar
• Tolek A , WongkhamC, ProungvitayaSet al. Serum alpha1beta-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma. Exp. Biol. Med. (Maywood)237 ( 10 ), 1142 – 1149 (2012).
   PubMed Web of Science ®Google Scholar
• Choi JW , LiuH, ShinDHet al. Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients. Proteomics13 ( 15 ), 2361 – 2374 (2013).
   PubMed Web of Science ®Google Scholar
• Jeong DH , KimHK, PrinceAEet al. Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix. J. Gynecol. Oncol.19 ( 3 ), 173 – 180 (2008).
   PubMedGoogle Scholar
• Opstal-Van Winden AW , KropEJ, KaredalMHet al. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case–control study. BMC Cancer11, 381 (2011).
   PubMed Web of Science ®Google Scholar
• Song HJ , XueYL, QiuZL, LuoQY. Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases. Nucl. Med. Commun.34 ( 12 ), 1196 – 1203 (2013).
   PubMed Web of Science ®Google Scholar
• Shen CT , WeiWJ, QiuZL, SongHJ, LuoQY. Afamin promotes glucose metabolism in papillary thyroid carcinoma. Mol. Cell. Endocrinol.434, 108 – 115 (2016).
   PubMed Web of Science ®Google Scholar
• Wu GX , LinYM, ZhouTH, GaoH, PeiG. Significant down-regulation of alpha-albumin in human hepatoma and its implication. Cancer Lett.160 ( 2 ), 229 – 236 (2000).
   PubMed Web of Science ®Google Scholar
• Pang L , LiQQ, LiY, LiuY, DuanN, LiHX. Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis. Clin. Proteomics15, 5 (2018).
   PubMed Web of Science ®Google Scholar
• Rao PV , LuX, StandleyMet al. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care30 ( 3 ), 629 – 637 (2007).
   PubMed Web of Science ®Google Scholar
• Mucha K , BakunM, JazwiecRet al. Complement components, proteolysis-related, and cell communication-related proteins detected in urine proteomics are associated with IgA nephropathy. Pol. Arch. Med. Wewn.124 ( 7-8 ), 380 – 386 (2014).
   PubMed Web of Science ®Google Scholar
• Levey AS , StevensLA, SchmidCHet al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med.150 ( 9 ), 604 – 612 (2009).
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI) . User verification of performance for precision and trueness; approved guideline. In : CLSI Document EP15-A2 (2nd Edition). Clinical and laboratory standards Institute, Wayne, PA, USA ( (2005).
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI) . Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. In : CLSI Document EP6-A, Clinical and laboratory standards Institute, Wayne, PA, USA (2003).
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI) . Protocols for determination of limits of detection and limits of quantitation; approved guideline. In : CLSI Document EP17-A. Clinical and laboratory standards Institute, Wayne, PA, USA (2004).
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI) . Defining, establishing, and verifying reference intervals in the clinical laboratory; approved Guideline. In : CLSI Document C28-A3 (3rd Edition). Clinical and laboratory standards Institute, Wayne, PA, USA (2008).
   Google Scholar
• Shao C , WangY, GaoY. Applications of urinary proteomics in biomarker discovery. Sci. China Life Sci.54 ( 5 ), 409 – 417 (2011).
   PubMed Web of Science ®Google Scholar
• Dieplinger H , DieplingerB. Afamin-A pleiotropic glycoprotein involved in various disease states. Clin. Chim. Acta446, 105 – 110 (2015).
   PubMed Web of Science ®Google Scholar
• Vivekanandan-Giri A , SlocumJL, BullerCLet al. Urine glycoprotein profile reveals novel markers for chronic kidney disease. Int. J. Proteomics2011, 214715 (2011).
   PubMedGoogle Scholar
• Geyer PE , HoldtLM, TeupserD, MannM. Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol.13 ( 9 ), 942 (2017).
   PubMed Web of Science ®Google Scholar
• Topbas C , SwickA, RazaviM, AndersonNL, PearsonTW, BystromC. Measurement of lipoprotein-associated phospholipase A2 by use of 3 different methods: exploration of discordance between ELISA and activity assays. Clin. Chem.64 ( 4 ), 697 – 704 (2018).
   PubMed Web of Science ®Google Scholar
• Heiser M , Hutter-PaierB, JerkovicLet al. Vitamin E binding protein afamin protects neuronal cells in vitro. J. Neural Transm. Suppl. ( 62 ), 337 – 345 (2002).
   PubMedGoogle Scholar
• Jing W , VaziriND, NunesAet al. LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD. Am. J. Transl. Res.9 ( 12 ), 5473 – 5484 (2017).
   PubMed Web of Science ®Google Scholar
• Volpe CMO , Villar-DelfinoPH, Dos AnjosPMF, Nogueira-MachadoJA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis.9 ( 2 ), 119 (2018).
   PubMed Web of Science ®Google Scholar